Resources: Page 92

PET/MRI shows prowess for nodal staging in breast cancer
By Amerigo Allegretto
Sunday, November 28 | 10:30 a.m.-11:30 a.m. | SSNMMI01-4 | Room N226In this presentation, researchers will compare nodal staging between CT, MRI, and FDG-PET/MRI in patients with newly diagnosed breast cancer.
November 23, 2021
MRI scans show how autism affects young brains over time
By Kate Madden Yee
Researchers from Yale University have found that autism affects the microstructure of white matter in the brains of adolescents and young adults over time as indicated on MRI scans. The study results are being presented at the upcoming RSNA 2021 meeting.
November 22, 2021
2021 11 19 17 00 3081 2021 11 23 Rsna Autism Weber 20211119172037
Median promotes new lung cancer screening results
By AuntMinnie.com staff writers
Median Technologies is highlighting clinical results that show that its iBiopsy lung cancer screening deep-learning algorithm has a sensitivity of 93.1% and a specificity of 96.2% for characterizing lung nodules on low-dose chest CT.
November 22, 2021
2016 12 21 15 11 05 414 Lung Cancer 400
Riverain to highlight partnerships at RSNA 2021
By AuntMinnie.com staff writers
Artificial intelligence (AI) software developer Riverain Technologies plans to announce the growth of relationships with other companies in lung imaging at the RSNA 2021 annual meeting.
November 22, 2021
2019 06 11 22 35 5932 Heart Pulmonary Trunk 400
Visage to debut Visage 7 Video Reports at RSNA 2021
By AuntMinnie.com staff writers
Enterprise imaging firm Visage Imaging will introduce Visage 7 Video Reports at RSNA 2021.
November 22, 2021
2020 06 26 17 17 1126 Visage Rsna 2019 400
Philips launches new MRI scanners on eve of RSNA 2021
By Brian Casey
With the start of RSNA 2021 one week away, Philips is launching new 1.5-tesla and 3-tesla MRI scanners, as well as software-based workflow enhancements that are designed to enable radiology facilities to operate more efficiently.
November 22, 2021
2021 11 22 22 11 1128 2021 11 23 Philips Mri 20211122220126
Road to RSNA 2021: Molecular Imaging Preview
By Will Morton
Presentations specific to COVID-19 are among the molecular imaging scientific sessions offered at RSNA 2021. Attendees will also enjoy research in oncologic and brain imaging, radionuclide therapy, PET radiopharmaceuticals, technical advances, and more.
November 22, 2021
2017 11 02 17 42 1107 Road To Rsna 400
FDG-PET/CT scans assessed for clinical utility in COVID-19
By Will Morton
Monday, November 29 | 9:30 a.m.-10:30 a.m. | SSNMMI03-4 | Room S402In this talk, researchers will present a study to determine imaging findings and the potential clinical utility of FDG-PET/CT in patients with laboratory-confirmed COVID-19. They suggest FDG-PET/CT scans could be helpful in predicting disease severity.
November 22, 2021
Combining radiomics, AI with PET/MRI helps assess nodal status
By Amerigo Allegretto
Sunday, November 28 | 10:30 a.m.-11:30 a.m. | SSNMMI01-3 | Room N226Here, researchers will talk about how applying radiomics and machine learning to FDG-PET/MRI can noninvasively assess nodal status and treatment planning for breast cancer patients.
November 22, 2021
PET/MRI shows prowess for nodal staging in breast cancer
By Amerigo Allegretto
Sunday, November 28 | 10:30 a.m.-11:30 a.m. | SSNMMI01-4 | Room N226In this presentation, researchers will compare nodal staging between CT, MRI, and FDG-PET/MRI in patients with newly diagnosed breast cancer.
November 22, 2021
Is FDG uptake normal in patients after ascending aorta replacement?
By Will Morton
Prerecorded, available throughout meeting | SPR-NMMI-16In this presentation, Dutch cardiovascular imaging specialists will discuss interpreting normal F-18 FDG uptake on PET/CT after patients undergo combined aortic valve and ascending aorta replacement.
November 22, 2021
New radiotracer promising for diagnosing infection in vivo
By Will Morton
Prerecorded, available throughout meeting | SPR-NMMI-14In this session exploring new frontiers in PET radiopharmaceuticals, researchers from the University of California, San Francisco will present results from an ongoing trial of a new carbon-11-labeled radiotracer that targets bacterial infection.
November 22, 2021
Previous Page
Page 92 of 725
Next Page